Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on , under the ticker symbol "TEM." [6][7]
Complete Tempus AI Inc. stock information by Barron's. View real-time TEM stock price and news, along with industry-best analysis.
Stock analysis for Tempus AI Inc (TEM:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
TEM: Tempus AI Inc Stock Price Quote - NASDAQ GS - Bloomberg
Find the latest Tempus AI, Inc. (TEM) stock quote, history, news and other vital information to help you with your stock trading and investing.
TEM's current price target is $71.36. Learn why top analysts are making this stock forecast for Tempus AI at MarketBeat.
Tempus Hub provides a secure platform for managing your Tempus-related activities and information.
Join Tempus and help advance precision medicine. Explore open roles in engineering, research, clinical operations, and more to build the future of healthcare.
Tempus is a healthcare technology company advancing the use of AI in precision oncology. By integrating comprehensive molecular and clinical data, we deliver actionable insights that help oncologists make more informed decisions throughout the patient journey.
Founded in 2025, Actum News operates in the Media & Entertainment sector offering an AI-powered news app that delivers short, unbiased, and personalized news ...